NeurAxis (NRXS) Insider Trading & Ownership $2.38 -0.04 (-1.45%) As of 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NeurAxis (NASDAQ:NRXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$31,252.45Number OfInsiders Selling(Last 12 Months)0 Get NRXS Insider Trade Alerts Want to know when executives and insiders are buying or selling NeurAxis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NRXS Insider Buying and Selling by Quarter NeurAxis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/21/2025Brian HannaschMajor ShareholderBuy18,065$1.73$31,252.45 (Data available from 1/1/2013 forward) NRXS Insider Trading Activity - Frequently Asked Questions Who is on NeurAxis's Insider Roster? The list of insiders at NeurAxis includes Brian Hannasch. Learn more on insiders at NRXS. What percentage of NeurAxis stock is owned by insiders? 15.20% of NeurAxis stock is owned by insiders. Learn more on NRXS's insider holdings. Which NeurAxis insiders have been buying company stock? The following insider purchased NRXS shares in the last 24 months: Brian Hannasch ($31,252.45). How much insider buying is happening at NeurAxis? Insiders have purchased a total of 18,065 NRXS shares in the last 24 months for a total of $31,252.45 bought. NeurAxis Key ExecutivesMr. Brian Carrico (Age 42)President, CEO & Director Compensation: $839.4kMr. Timothy Robert Henrichs (Age 51)Chief Financial Officer Compensation: $23.84kDr. Adrian Miranda (Age 54)Senior VP of Science & Technology and Chief Medical Officer Compensation: $323.05kDr. Thomas Carrico (Age 67)Chief Regulatory Officer and Compliance Officer & Privacy Officer Compensation: $411.1kDr. Christopher Robin Brown D.D.S. (Age 70)Founder, Director of Innovation & Director More Insider Trading Tools from MarketBeat Related Companies electroCore Insider Trades Alpha Pro Tech Insider Trades Daxor Insider Trades Apyx Medical Insider Trades Outset Medical Insider Trades TELA Bio Insider Trades Modular Medical Insider Trades Precision Optics Insider Trades DarioHealth Insider Trades Spectral AI Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:NRXS) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRXS Stock Free NRXS Stock Alerts